Vision Biotechnology Berlin

What is publicly disclosed.

A completed PCR-test manufacturing-capability programme within Vision Biotechnology’s disclosed international network.

The project is classified as PCR-test manufacturing capability. Its public status is Completed, and the published location is Berlin, Germany. Where the disclosed area is available, it is stated as Not publicly stated; this value is not converted into a cleanroom, operating or ownership claim.

Scope is separated by work package.

• PCR production infrastructure
• Equipment and process integration
• Production-capability establishment
• Controlled technical implementation

Each item describes the disclosed engagement boundary. It does not imply services outside the listed scope or transfer responsibility from the client, operator, technology owner or competent authority.

Evidence follows the Seven-Gate Framework.

Reference evidence is assessed against investment definition, concept design, engineering, procurement and technology integration, quality readiness, commissioning and operational handover. The applicable gates depend on the contracted work packages. A design-only engagement is not presented as construction; equipment supply is not presented as complete EPC.

What this page does not claim.

No facility area, installed capacity or regulatory status is published on this page.

Certification, accreditation, product registration and market authorisation remain subject to independent competent authorities and the accountable legal entity. Commercial values, restricted drawings, capacities and client documentation are released only where authorised or during qualified due diligence under NDA.

Connect the reference to an investable project scope.

The reference demonstrates a disclosed technical engagement, not a generic promise of identical cost, capacity or schedule elsewhere. A new programme must be sized for destination-market demand, utilities, workforce, regulatory pathway, site conditions and intended operating model.